Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominic Sinibaldi

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Mathematical Biosciences|February 28, 2002
A simple method to improve probe set estimates from oligonucleotide arraysEmmanuel N Lazaridis, Dominic Sinibaldi, Gregory Bloom, et al.
Kidney360|April 4, 2022
Collagen Type III and VI Remodeling Biomarkers Are Associated with Kidney Fibrosis in Lupus NephritisFederica Genovese, Ahmad Akhgar, Sung Sam Lim, et al.
Lupus Science & Medicine|December 13, 2018
Type I interferon receptor blockade with anifrolumab corrects innate and adaptive immune perturbations of SLEKerry A Casey, Xiang Guo, Michael A Smith, et al.
Lupus Science & Medicine|January 30, 2023
Urinary markers differentially associate with kidney inflammatory activity and chronicity measures in patients with lupus nephritisAhmad Akhgar, Dominic Sinibaldi, Lingmin Zeng, et al.
Arthritis Care & Research|October 27, 2025
The Renal Activity Index for Lupus Identifies Active Renal Disease and Treatment Response in Adult Patients With Systemic Lupus Erythematosus and Lupus NephritisHermine I Brunner, Ellen M Cody, Prasad Devarajan, et al.
Scientific Reports|October 10, 2019
SLE Plasma Profiling Identifies Unique Signatures of Lupus Nephritis and Discoid LupusMichael A Smith, Jill Henault, Jodi L Karnell, et al.
Oncogene|April 18, 2002
Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesisGuilian Niu, Kenneth L Wright, Mei Huang, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 10, 2020
Modulation of Cardiometabolic Disease Markers by Type I Interferon Inhibition in Systemic Lupus ErythematosusKerry A Casey, Michael A Smith, Dominic Sinibaldi, et al.
The New England Journal of Medicine|June 26, 2024
Eosinophil Depletion with Benralizumab for Eosinophilic EsophagitisMarc E Rothenberg, Evan S Dellon, Margaret H Collins, et al.
Scientific Reports|March 12, 2020
Using the circulating proteome to assess type I interferon activity in systemic lupus erythematosusMichael A Smith, Chia-Chien Chiang, Kamelia Zerrouki, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Mathematical Biosciences|February 28, 2002
A simple method to improve probe set estimates from oligonucleotide arraysEmmanuel N Lazaridis, Dominic Sinibaldi, Gregory Bloom, et al.
Kidney360|April 4, 2022
Collagen Type III and VI Remodeling Biomarkers Are Associated with Kidney Fibrosis in Lupus NephritisFederica Genovese, Ahmad Akhgar, Sung Sam Lim, et al.
Lupus Science & Medicine|December 13, 2018
Type I interferon receptor blockade with anifrolumab corrects innate and adaptive immune perturbations of SLEKerry A Casey, Xiang Guo, Michael A Smith, et al.
Lupus Science & Medicine|January 30, 2023
Urinary markers differentially associate with kidney inflammatory activity and chronicity measures in patients with lupus nephritisAhmad Akhgar, Dominic Sinibaldi, Lingmin Zeng, et al.
Arthritis Care & Research|October 27, 2025
The Renal Activity Index for Lupus Identifies Active Renal Disease and Treatment Response in Adult Patients With Systemic Lupus Erythematosus and Lupus NephritisHermine I Brunner, Ellen M Cody, Prasad Devarajan, et al.
Scientific Reports|October 10, 2019
SLE Plasma Profiling Identifies Unique Signatures of Lupus Nephritis and Discoid LupusMichael A Smith, Jill Henault, Jodi L Karnell, et al.
Oncogene|April 18, 2002
Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesisGuilian Niu, Kenneth L Wright, Mei Huang, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 10, 2020
Modulation of Cardiometabolic Disease Markers by Type I Interferon Inhibition in Systemic Lupus ErythematosusKerry A Casey, Michael A Smith, Dominic Sinibaldi, et al.
The New England Journal of Medicine|June 26, 2024
Eosinophil Depletion with Benralizumab for Eosinophilic EsophagitisMarc E Rothenberg, Evan S Dellon, Margaret H Collins, et al.
Scientific Reports|March 12, 2020
Using the circulating proteome to assess type I interferon activity in systemic lupus erythematosusMichael A Smith, Chia-Chien Chiang, Kamelia Zerrouki, et al.
Pageof 2